Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
36.88
+2.57 (7.49%)
At close: Aug 13, 2025, 4:00 PM
37.04
+0.16 (0.43%)
After-hours: Aug 13, 2025, 6:24 PM EDT
Cytokinetics Employees
Cytokinetics had 498 employees as of December 31, 2024. The number of employees increased by 75 or 17.73% compared to the previous year.
Employees
498
Change (1Y)
75
Growth (1Y)
17.73%
Revenue / Employee
$172,165
Profits / Employee
-$1,217,492
Market Cap
4.42B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CYTK News
- 5 days ago - Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - Cytokinetics Merits A Speculative Buy Rating - Seeking Alpha
- 20 days ago - Cytokinetics to Announce Second Quarter Results On August 7, 2025 - GlobeNewsWire
- 26 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 weeks ago - Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 - GlobeNewsWire
- 2 months ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program - GlobeNewsWire